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Treatment of chronic ulcers, often recalcitrant to usual methods of therapy, poses a
problem which may be extremely difficult. Prolonged periods of bed rest are not always
practical; supportive and even surgical modalities frequently fail. Therefore, any new agent
which offers a reasonable basis for success is worth clinical investigation.
Laboratory experiments with Panthenol,f the hydroxy-analog of pantothenic acid,
were called to our attention. This alcohol (d-a, .y - dihydroxy-N- (3-hydroxypropyl) -.-




It is approximately as effective as calcium pantothenate in overcoming pantothenic
acid deficiency states in black rats and in mice; stunted growth and achromotrichia in
black rats, and alopecia in mice. On oral administration it is converted by rat and by man
into pantothenic acid. Quantitatively the amounts of pantothenic acid excreted in the
urine following ingestion of Panthenol are actually greater than with an equivalent dose of
calcium pantothenate. The intravenous administration of sodium pantothenate or of
Panthenol to normal subjects increases the urinary output of pantothenic acid by equiva-
lent amounts.
The cutaneous application of Panthenol to pantothenic acid deficient rats produces a
normal pantothenic acid concentration in the liver, and reverses deficiency states (1).
Furthermore, it has been demonstrated that pantothenic acid in rats is necessary for
normal function of epithelial tissue (2). This finding, and the evidence of excellent absorp-
tion of Panthenol from the skin suggested its use in defective wound healing. Preliminary
studies with an ointment containing Panthenol in 5% concentration on patients with
severe burns, infected operative wounds, and decubital ulcers, showed unusually rapid
epithelization.(3, 4)
It therefore seemed advisable to undertake additional studies involving the cutaneous
application of Panthenol to clinical conditions requiring stimulation of granulation tissue
and epithelization, such as various recalcitrant suppurative lesions and chronic ulcers.
CLINICAL STUDY
A number of patients at Bellevue Hospital, on the dermatologic wards and in the Out-
Patient Department, were selected for study. Of these, 51 remained under observation for
sufficient time to be included in the series. There were 42 men and 9 women, varying in
age from 15 to 83 years. Thirty-five were hospitalized and 16 treated in the clinic.
The material used was Panthenol incorporated in 5% concentration in a lanolin base or
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in a carbowax base. Both bases were used interchangeably during the period of study. A
jelly which was also tried at the inception of the investigation was soon discarded because
of its unsatisfactory physical properties. The Panthenol ointment was applied directly to
the lesion and covered with a gauze dressing. Reapplication was made in 24 or 48 hours,
depending on the stage of healing. Badly infected lesions were first cleansed with weak
solutions of either hydrogen peroxide or potassium permanganate. Of the 51 patients, 28
cleared entirely while under observation and 17 showed some degree of improvement.
Two patients did not respond to therapy at all, and six developed complications.
TABLE I
Patients treated with 5% panthenol ointment
BASE USED IMPROVED OTHERNO. OP
DIAGNOSIS PA- CURED
TIENTS Carbo-
L.no- Jelly Marked Slight Worse
Pyoderma with
ulceration 14 6 7 2 11 1 1
Pyoderma, super-
ficial 2 2 1 1 1
Hypostatic der-
matitis with ul-
ceration 15 4 11 4 4 2 1 1 3
Decubitus ulcer.. 2 2 1 2
Radiodermatitis
with ulceration. 1 1 1
Factitial ulcer.... 2 2 1 2
Traumatic ulcer.. 7 2 5 4 3
Arteriosclerotic
ulcer 3 2 3 2 1
Trophic ulcer 1 1 1
Sickle cell ulcer. . 1 1 1
Infectious eczem-
atoid dermatitis 2 1 1 2
Dermatitis her-
petiformis 1 1 1
Total 51 22 33 2 28 12 2 2 2 4
Several patients were treated with more than one preparation of Panthenol thus ac-
counting for the disparity in figures.
CONCLUSIONS
Topical application of Panthenol, the alcoholic analog of pantothenic acid, incorporated
in ointment bases containing either lanolin or carbowax, favorably influenced the course
of various ulcerative and pyogenic dermatoses. A majority healed and many showed various
degrees of improvement. Many patients had had previous prolonged trials of therapy with
other modalities with indifferent resu]ts. There were a few side reactions, but none was
proved due to either primary irritation or allergy.
It is likely that with the use of auxiliary and supportive therapy (such as could be in-
cluded in actual treatment but not in the present clinical investigation,) particularly in
crural ulcers, Panthenol will produce even better results than in this study.
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